Bourgeon Capital Management’s Galmed Pharmaceuticals GLMD Stock Holding History

Bourgeon Capital Management’s Portfolio GLMD Stock Details GLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Hold	0	–	-$16	–	209
2023 Q4	–	Hold	0	–	–	–	399
2023 Q3	–	Hold	0	–	–	–	395
2023 Q2	–	Hold	0	–	–	–	327
2023 Q1	–	Hold	0	–	–	–	306
2022 Q4	–	Hold	0	–	–	–	353
2022 Q3	–	Hold	0	–	–	–	396
2022 Q2	–	Hold	0	–	–	–	293
2022 Q1	–	Hold	0	–	–	–	274
2021 Q4	–	Hold	0	–	–	–	257
2021 Q3	–	Hold	0	–	–	–	268
2021 Q2	–	Hold	0	–	–	–	263
2021 Q1	–	Hold	0	–	–	–	258
2020 Q4	–	Hold	0	–	–	–	247
2020 Q3	–	Hold	0	–	–	–	254
2020 Q2	–	Hold	0	–	–	–	235
2020 Q1	–	Hold	0	–	–	–	239
2019 Q4	–	Hold	0	–	–	–	218
2019 Q3	–	Hold	0	–	–	–	223

Other funds holding GLMD

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Walleye Capital

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Two Sigma Advisers

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return